Sichuan Huiyu Pharmaceutical Co Ltd (688553) — Cash Flow Reinvestment Rate
Sichuan Huiyu Pharmaceutical Co Ltd (688553) has a Cash Flow Reinvestment Rate of 0.52x as of September 2025, reinvesting CN¥30.63 Million (capex CN¥30.63 Million ) from operating cash flow of CN¥58.54 Million. Explore capital reinvestment ratio of Sichuan Huiyu Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sichuan Huiyu Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2018–2024)
Historical reinvestment intensity for Sichuan Huiyu Pharmaceutical Co Ltd across 7 annual periods. Also explore balance sheet size of Sichuan Huiyu Pharmaceutical Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Sichuan Huiyu Pharmaceutical Co Ltd (2018–2024)
Year-by-year capital reinvestment analysis for Sichuan Huiyu Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 688553 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.17x | CN¥526.72 Million | CN¥242.96 Million | CN¥128.18 Million | ▼ -82.4% |
| 2023 | 12.35x | CN¥826.75 Million | CN¥66.93 Million | CN¥296.72 Million | ▲ +273.0% |
| 2022 | 3.31x | CN¥642.65 Million | CN¥194.06 Million | CN¥461.61 Million | ▼ -35.9% |
| 2021 | 5.17x | CN¥2.31 Billion | CN¥446.36 Million | CN¥433.45 Million | ▲ +421.4% |
| 2020 | 0.99x | CN¥384.33 Million | CN¥387.95 Million | CN¥158.24 Million | ▼ -16.9% |
| 2019 | 1.19x | CN¥388.90 Million | CN¥326.22 Million | CN¥110.00 Million | ▲ +567.8% |
| 2018 | 0.18x | CN¥23.04 Million | CN¥129.06 Million | CN¥23.04 Million | — |